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Abstract
Over the past decade rapid advances have occurred in the understanding of RNA expression and its regulation. Quantitative
polymerase chain reactions (qPCR) have become the gold standard for quantifying gene expression. Microfluidic next
generation, high throughput qPCR now permits the detection of transcript copy number in thousands of reactions
simultaneously, dramatically increasing the sensitivity over standard qPCR. Here we present a gene expression analysis
method applicable to both standard polymerase chain reactions (qPCR) and high throughput qPCR. This technique is
adjusted to the input sample quantity (e.g., the number of cells) and is independent of control gene expression. It is
efficiency-corrected and with the use of a universal reference sample (commercial complementary DNA (cDNA)) permits the
normalization of results between different batches and between different instruments – regardless of potential differences
in transcript amplification efficiency. Modifications of the input quantity method include (1) the achievement of absolute
quantification and (2) a non-efficiency corrected analysis. When compared to other commonly used algorithms the input
quantity method proved to be valid. This method is of particular value for clinical studies of whole blood and circulating
leukocytes where cell counts are readily available.
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Introduction
Over the past decade a rapid increase has occurred in the
understanding of RNA expression and its regulation. Quantitative
polymerase chain reaction(s) (qPCR) have become the gold
standard for measuring gene expression. Accurate analysis of
qPCR data is crucial for optimal results and a number of well-
defined methods are in use to calculate gene expression. These
include the comparative CT method [1], the efficiency corrected
method [2] and sigmoidal curve fitting methods [3], all of which
provide relative quantitative information. A standard curve of
serial dilutions of a known sample is additionally required to
measure the absolute number of transcript copies in a sample.
For most scientific purposes, relative quantification, expressed as
fold change, is sufficient to provide the required information.
Hence, the comparative CT and efficiency corrected methods, as
well as the sigmoidal curve fitting methods are widely employed,
but each method has strengths and weaknesses. The comparative
CT method by Livak et al. [1] has the advantage of ease of use but
is based on the assumption that transcript amplification efficiencies
are 100%. In the efficiency corrected method by Pfaffl [2] the
relative expression ratio is calculated only from the real-time PCR
efficiencies and the crossing point deviation of an unknown sample
versus a control. This model needs no calibration curve and gives
improved quantification but is complex to use and requires
determination of the amplification efficiency.
Furthermore, all of these methods require the use of reference
(control or housekeeping) genes to correct for unequal amounts of
biological material that may exist between the tested samples. The
commonly used housekeeping genes were initially selected on the
basis of their abundance and expression in a wide variety of tissues.
An absolute requirement and widely held assumption of house-
keeping genes has been that their expression is constant under all
conditions and is unaffected by the experimental conditions [4].
However, the expression of commonly used housekeeping genes
has since been found to vary considerably in many conditions [5–
12]. In the case of in vitro or ex-vivo experiments it is usually
possible to perform additional experiments to identify and validate
appropriate control genes. In the case of clinical studies, however,
where sample volumes are usually limited, it is rarely possible to
test gene expression before and after the experiment (i.e., before
and after the disease occurs).
The advent of next generation high throughput qPCR, based
on reaction volumes scaled to the nanoliter range and with a
consequent dramatic reduction in the volume of reagents and
samples, has been a major advance for the analysis of clinical
samples [13]. The Fluidigm Biomark system, one of the new high-
throughput reverse transcription PCR (HT RT-qPCR) systems,
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simultaneously during a single run, in a total of 9216 reactions.
This allows many more transcripts to be studied from routine
clinical samples, representing a 40 to 50 fold improvement in
efficiency over standard qPCR [14,15]. However, HT RT-qPCR
has also raised new issues; for example, transcript amplification
efficiency may be affected by potential interactions (i.e., primer
dimer, competition) between multiple primers during the pre-
amplification and amplification steps.
Here, we present a method for the measurement of the absolute
gene expression for standard and high throughput qPCR
experiments based on the input sample quantity. Based on this
method three equations were developed: (1) for the measurement
of fold change differences between target and control samples; (2)
for the comparison of results from different experiments and
different machines after normalization to a reference cDNA
sample; (3) for analyses of samples of unknown efficiency. Gene
expression results calculated using the input quantity method were
then validated in a serial dilution series of commercial cDNA and
using different starting cell concentrations. In clinical samples, fold
change values calculated with the input quantity method were
compared to values obtained using other commonly used
algorithms. The input quantity method has the advantages of
avoiding the use of control genes, of being efficiency corrected,
and providing both fold change and absolute results. This method
can also be applied in the verification and quantification of
qualitative results from microarray studies for multiple genes.
Theory
1. Requirements for the input quantity method
The input quantity method has several requirements. First, the
amount of material used for RNA extraction has to be measured:
for example, cell count is required for cell suspensions (e.g.,
peripheral blood mononuclear cells (PBMCs), lymphocytes and
cell lines), white blood cell (WBC) counts are needed for whole
blood studies and tissue volumes are needed for solid tissues.
Secondly, for reverse transcription of RNA to cDNA the same
reagents, volumes and protocols for a given experiment need to be
used. Thirdly, the amplification efficiency and correlation
coefficients (R
2) should be assessed for each gene assay based on
a standard dilution series. Finally, full application of this method
requires the use of a standard sample (i.e., commercial cDNA –
reverse transcribed cDNA from RNA extracted from all human
tissues) for each measurement.
2. Mathematical model for qPCR amplification
As per Livak et al. [1], in the qPCR target cDNA sequence is
amplified in an exponential fashion:
Xn~X0|(1zE)
n ð1Þ
where Xn is the number of target cDNA molecules after n cycles,
X0 is the number of cDNA molecules before amplification, E is the
efficiency of target cDNA amplification and n is the number of
amplification cycles. In the case of perfect efficiency (E=100%)
the number of target cDNA molecules doubles every cycle.
In qPCR, the number of target cDNA molecules for a given
sample is reflected by the threshold cycle - or according to the
MIQE guidelines [4], quantification cycle (Cq) - because Cq is the
intersection between an amplification curve and threshold. The
threshold is the level of fluorescence above background fluores-
cence – set at the same level for all samples in the experiment.
Each sample that crosses the threshold (regardless of the
amplification cycle number) has the same fluorescence intensity
hence the same target cDNA copy number.
XnCq~X0|(1zE)
nCq~K ð2Þ
where XnCq is the number of target cDNA molecules at the Cq,
nCq is the cycle number at which amplification crosses the
threshold and K is a constant value for all samples in a given
experiment.
3. Analysis normalized to input sample quantity
In order to adjust the results of gene expression to unequal
amounts of starting material the number of cells used for RNA
extraction has to be incorporated into Equation 2.
X0~XC|cc ð3Þ
where Xc is the transcript number per cell and cc is the number of
cells used for RNA extraction (e.g., complete blood count for
whole blood analysis, or hemocytometer cell count for cell subset
analysis). Hence,
K~(XC|cc)|(1zE)
nCq ð4Þ
Therefore to compare gene expression between target (T) and
control (C) samples where E and K are the same for T and C, ccT
is the input cell count for target sample and ccC is the cell input for
the control sample. For the target samples the following formula is
obtained:
K~(TC|ccT)|(1zE)
nCq,T ð5Þ
where TC is the number of transcripts per cell in the target
samples.
For the reference or control samples the following formula is
obtained.
K~(Cc|ccC)|(1zE)
nCq,C ð6Þ
where CC is the number of transcripts per cell in the reference
samples.
As K is constant, Equations 4 and 5 equal each other:
(TC|ccT)|(1zE)
nCq,T~(CC|ccC)|(1zE)
nCq,C ð7Þ
To obtain the comparison between target and control samples:
TC
CC
~
ccC
ccT
|(1zE)
(nCq,C{nCq,T) ð8Þ
This way we can obtain the measure of gene expression
expressed as a fold change difference between the test and control
samples.
4. Analysis normalized to input quantity and normalized
to standard cDNA
When a standard reference sample is introduced, for example a
sample that contains a high concentration of studied transcripts,
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for sample X with a starting quantity of cc is:
K~(XC|cc)|(1zE)
nCq,X ð9Þ
K for a standard cDNA of uniform quantity is:
K~cDNA0|(1zE)
nCq,cDNA ð10Þ
Normalizing to cDNA:
(XC|ccX)|(1zE)
nCq,X~cDNA0|(1zE)
nCq,cDNA ð11Þ
XC~cDNA0|
(1zE)
(nCq,cDNA{nCq,X)
ccX
ð12Þ
Since the number of transcripts before amplification in standard
cDNA (cDNA0) is constant we may assume it is equal to 1 then:
XC~
(1zE)
(nCq,cDNA{nCq,X)
ccX
ð13Þ
To obtain the comparison between test and control samples, the
respective Tc and Cc are calculated using Equation 13. Then Tc is
divided by Cc to obtain the measure of gene expression, expressed
as a fold change.
5. Analysis normalized to input quantity and/or
normalized to standard cDNA without known efficiency
If E for the working primers is not assessed in the experiment,
one may make an assumption that the E equals 100% -then
Equation 8 is:
T0
C0
~
cc,C
cc,T
|2(nCq,C{nCq,T) ð14Þ
Whereas, adjusting to the standard cDNA sample, for sample X
Equation 12 is:
XC~
2(nCq,cDNA{nCq,X)
ccC
ð15Þ
Materials and Methods
To assess the reliability of the input quantity method, the
stability of expression values calculated across serial dilutions of a
standard cDNA sample and of different starting numbers of two
samples of peripheral blood mononuclear cells (PBMCs) were
determined. The validity of the input quantity method was
assessed by comparison to fold changes obtained using the Livak
[1] and Pfaffl [2] methods for three transcripts in a cohort of stroke
patients and control subjects.
The Institutional Review Board at the State University of New
York (SUNY) Downstate Medical Center approved the study. All
study participants and/or authorized representatives gave full and
signed informed consent. Where applicable, the conduct and
reporting of the study are in accordance with the MIQE criteria
[4]. The detailed laboratory protocols but not the data analysis
described in this manuscript have been previously published [14].
1. RNA extraction and reverse transcription
Whole blood was obtained from 38 ischemic stroke patients
between 7 and 90 days post stroke and from 17 sex- and race-
matched control subjects. RNA was extracted using column
separation (All-in-One Kit; Norgen Biotek, Thorold, Ontario,
Canada) from 100 ml of whole blood and from a median of 2.0
million CD4
+ cells. Peripheral blood mononuclear cells (PBMCs)
from two control subjects were used for the cell dilution
experiment, with RNA isolated from triplicate samples of 2
million, 1 million, 0.5 million and 0.25 million cells. Cellular
counts (millions of cells per ml) were measured using a
hemocytometer for CD4
+ and for PBMCs; for whole blood, the
total white blood cell count was obtained from the laboratory-
measured complete blood count (CBC) in each study subject.
Density gradient centrifugation with Histopaque 1077 and 1119
(Sigma-Aldrich, St. Louis, MO) was used to separate the PBMC
fraction from the whole blood. Positive magnetic bead separation
(Miltenyi Biotec, Bergisch Gladbach, Germany) was used to
separate CD4
+ from PBMCs – the cellular purity was over 97%.
The extracted RNA was resuspended in 50 ml of elution solution
(All-in-One Kit protocol). cDNA was synthetized using the High
Capacity cDNA Reverse Transcription Kit (Life Technologies,
Carlsbad, CA), based on random hexamers, according to the
manufacturer’s protocol. Following the protocol, the proportion of
RNA solution to 2x RT master mix was 1:1.
2. Primer development, RT qPCR and HT-RT qPCR
The primers for qPCR were self-designed, commercially
synthesized by Invitrogen and wet tested using standard RT
qPCR (StepOnePlus Real-Time PCR Systems; Applied Biosys-
tems).
Standard RT qPCR (StepOnePlus Real-Time PCR Systems;
Applied Biosystems) was used to measure the expression of FDFT1
in the cell dilution experiment. Each sample and no template
control were measured in triplicate. Based on a standard dilution
series the efficiency for FDFT1 in this experiment was 94%.
HT RT-qPCR was run on the BioMark HD System, using
96696 Fluidigm Dynamic Arrays (Fluidigm, South San Francisco,
CA). HT-RT qPCR was used first, to measure the expression of
FUT4, CD3E, FDFT1 and B2M in serial dilutions of commercial
cDNA (Universal cDNA Reverse Transcribed by Random
Hexamer: Human Normal Tissues; Biochain, Newark, CA) and
second, to compare the expression of FDFT1, CD3E and B2M
between control subjects and stroke patients in whole blood and
CD4
+ T lymphocytes. Two 5 point, four-fold serial dilution series
of commercial cDNA were run in triplicate on two different plates.
The volumes of commercial cDNA (diluent) in each dilution were:
100 ml (1:1), 25 ml (1:4), 6.25 ml (1:16), 1.5625 ml (1:64) and
0.39 ml (1:256). According to the manufacturer’s protocol, the
assay for each HT RT-qPCR experiment contained 10 mlo f
cDNA. The efficiencies for the genes, assessed with HT RT-
qPCR, were: B2M- 87%, FDFT1- 86%, FUT4- 79% and CD3E-
79%. Five separate gene expression plates were used in this
experiment. To normalize the gene expression results for stroke
and control samples from different plates, a sample of commercial
cDNA (containing high concentrations of all of the transcripts
studied) of standard concentration and volume was run in
duplicate on each plate. Each raw gene expression result
qPCR Quantitative Data Analysis Method Based on Input Sample Quantity
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same gene in the commercial cDNA samples that were run on the
same plate (sample Cq value for gene X was subtracted from the
average commercial cDNA Cq for gene X).
3. Calculation of fold changes
Fold change differences between stroke patients and control
subjects for B2M and CD3E were calculated using the input
sample quantity method according to Equation 13. The relative
gene expression for B2M and CD3E were measured using the
comparative CT method of Livak et al. [1] and the efficiency
corrected method of Pfaffl [2]. For these calculations FDFT1 was
used as control gene as its expression was not different in stroke
patients compared to control subjects, based on the input quantity
method (p.0.05).
4. Statistical analyses
The statistical analyses were performed using ‘‘R’’, version
2.15.2. For the cDNA dilution analysis, linear regression modeling
was used. For the cell dilution series, the data were analyzed using
one way ANOVA, Welch’s correction for inhomogeneity of
variances and post hoc t. tests with false discovery rate correction.
For the analysis of the stroke versus control data, the 95% CI for
the fold change values were calculated using the R package
‘‘mratios’’ and Dunnetts method; Wilcoxon rank sum tests were
used for between group comparisons.
Results
1. Gene expression measurements across different input
volumes of a standard cDNA sample
To confirm the reliability of the sample input quantity method
the expression of 4 transcripts (FUT4, CD3E, FDFT1 and B2M)
was measured in 5 point and 4-fold two serial dilutions of a
standard cDNA sample. To measure the concentrations of each of
the four transcripts in the standard cDNA sample, the results were
normalized to the volume of diluent 100 ml (1:1), 25 ml (1:4),
6.25 ml (1:16), 1.5625 ml (1:64) and 0.39 ml (1:256). Using this
normalization procedure the same expression values were
expected across the range of dilutions of the standard cDNA
sample. The samples were run in triplicate on two separate plates
giving 6 readings per input volume. The expression of all four
genes calculated with the input quantity method was stable
(Table 1, Figure 1). Detailed data are provided in a supplemental
table (Table S1).
2. Reliability of gene expression measurements across
different starting numbers of cells
In order to determine the influence of variables present prior to
the RT qPCR step (cell counting, RNA isolation and RT PCR)
the expression of FDFT1 in different starting numbers of PBMCs
from two control subjects was measured. The raw data were
normalized to the starting number of cells for each subject. The
starting numbers of cells (2 million, 1 million, 0.5 million and 0.25
million) were within the range of the manufacturer’s recommen-
dations for RNA extraction (All-in-One Kit, Norgen Biotec).
Based on the input quantity method the expression of FDFT1
was significantly different across the input cell counts for both
subjects (p=1.4e-7, Subject 1 and p=5.5e-5, Subject 2) (Table 2).
Post hoc tests revealed that the expression of FDFT1 in the 0.25
million input cell count in both subjects differed significantly from
the other input cell concentrations: in Subject 1 (versus 2 million,
p=2.7e-6, versus 1 million, p=0.00016 and versus 0.5 million,
p=7.6e-5) and in Subject 2 (versus 2 million, p=5.9e-5, versus 1
million, p=1.3e-6 and versus 0.5 million, p=1.7e-6). Compari-
sons between the 2 million, 1 million and 0.5 million input cell
numbers were not statistically significant for both subjects (p,
0.05). Detailed data are provided in a supplemental table (Table
S2).
3. Expression of CD3E and B2M in the late phase of stroke
and in control subjects calculated using three methods
To assess the validity of the input quantity method using clinical
samples, the expression of CD3E and B2M in whole blood and in
CD4
+ T lymphocytes was compared between patients in the
delayed phase of stroke and control subjects. Fold change
differences in gene expression were measured using the input
quantity method (normalized to cell count), and the Livak and
Pfaffl methods.
By all methods B2M expression was significantly increased in
whole blood in the delayed phase of stroke and CD3E was
significantly increased in CD4 cells (Table 3). No alterations in the
expression of CD3E were found in whole blood. A borderline
increased in B2M expression in CD4 cells was found using the
input quantity method. Detailed data are provided in a
supplemental table (Table S3).
Discussion
Several gene expression analysis methods are in common use,
but the input quantity approach presented here offers two major
advantages. Firstly, this method is independent of control genes.
Secondly, with the assumptions of 1) uniform efficiency of RNA
extraction and RT qPCR and 2) a constant concentration and
volume of a standard sample, this method permits absolute
quantification, expressed as the fraction of transcripts in the
standard sample, across different experiments. The proposed
algorithm is efficiency corrected, although analysis of results
without known efficiency is also possible. With the use of a
standard sample, the input quantity method also permits the
comparison and analysis of results from different batches and
results acquired on different qPCR machines. Furthermore, with
the advent of HT RT-qPCR, this analytical method is also very
useful for clinical research, where sample volumes are limited.
Table 1. Expression of FUT4, CD3E, FDFT1 and B2M across serial volumes of a standard cDNA sample.
FUT4 CD3E FDFT1 B2M
Coefficient –4.3e-8 –6.43e-8 –3.8e-7 –3.3e-6
P value 0.49 0.65 0.61 0.48
R
2 –0.018 –0.028 –0.026 –0.016
Dilution coefficient, p and R
2 values were obtained from linear regression analysis for each transcript.
doi:10.1371/journal.pone.0103917.t001
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PLOS ONE | www.plosone.org 4 August 2014 | Volume 9 | Issue 8 | e103917Figure 1. Expression of FUT4, CD3E, FDFT1 and B2M in a standard dilution series of reference cDNA sample normalized to the volume
of diluent using sample input quantity method.
doi:10.1371/journal.pone.0103917.g001
Table 2. Expression of FDFT1 in cell dilution series.
2 million cells 1 million cells 0.5 million cells 0.25 million cells p
Subject 1 0.2660.01 0.2360.02 0.2460.06 0.1560.02** ,,0.01
Subject 2 0.04960.003 0.04160.005 0.04360.015 0.07260.013** ,,0.01
p values were calculated using a one-way ANOVA.
**Post hoc tests revealed that expression of FDFT1 in the 0.25 million input cell count differed significantly from the other input cell concentrations in both subjects.
doi:10.1371/journal.pone.0103917.t002
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permits gene expression to be measured across a wide range of
commercial cDNA. Although the performance of both RNA
extraction and RT qPCR may differ significantly across different
cell concentrations and kits [15], our results show that, using the
same protocol and reagents within the input quantities we tested,
these variables can be successfully controlled. Furthermore, the
expression of B2M and CD3E in study subjects calculated using
three methods was highly concordant.
The rationale for the use of housekeeping (or control or
reference genes) is to correct gene expression results, reflected as
differences in Cq values between target and control samples, that
could result from two main factors: different amounts of starting
material or different levels of expression. Traditionally, house-
keeping genes have been chosen on the basis of their abundance,
ubiquitous expression across tissues and the assumption that their
expression is stable under physiological and experimental condi-
tions. However, the expression of conventionally used housekeep-
ing genes varies considerably in many conditions. Therefore,
reference gene selection requires additional experiments to
validate gene expression stability under different experimental
conditions [6–12,14]. In many conditions, especially in the clinical
setting, it is not possible to measure the effect of the disease/
condition on reference gene expression.
The algorithm used for our sample input quantity method
employs normalization to the sample input quantity (cell count,
tissue volume etc.), which in result permits an absolute gene
expression analysis. This method varies from the relative analysis
approach, where results are normalized to reference gene
expression. Due to normalization to the input quantity (measured
in absolute scale) the measure of gene expression remains absolute,
as in our method. In contrast, the gene expression from the
relative analysis approach is based on the normalization to
reference gene expression. Thus the ratio of the target gene
expression to the reference gene expression represents a relative
measure. By introducing a standard sample (of a stable transcript
concentration), our method allows us to compare gene expression
between different experiments. Instead of directly measuring
transcript copy number- as it is commonly done in absolute
measurements of gene expression- in our method, the measured
gene expression is presented as a fraction of transcripts present in
the standard sample. This fraction can be converted to the
transcript copy number by measuring concentration of the target
gene in the standard sample.
The input quantity approach presented here can be applied to
clinical studies, to verify and quantitate microarray results, and to
large scale studies of gene or microRNA expression. Having
knowledge of the input cell count for all samples and the use of a
uniform standard, first, allows normalization to the amount of
starting material, and second, the use of the same standard allows
normalization of results between different laboratories and
different equipment.
Supporting Information
Table S1 Detailed data for analysis in Result Section 1.
(XLSX)
Table S2 Detailed data for analysis in Result Section 2.
(XLSX)
Table S3 Detailed data for analysis in Result Section 3.
(XLSX)
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